BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

5:38 PM
 | 
Oct 05, 2012
 |  BC Extra  |  Company News

Veloxis, Chiesi in deal for LCP-Tacro

Veloxis Pharmaceuticals A/S (CSE:VELO) granted Chiesi Farmaceutici S.p.A. (Parma, Italy) exclusive rights to commercialize LCP-Tacro tacrolimus in Europe, Turkey and the Commonwealth of Independent States...

Read the full 116 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >